NCT01867489

Brief Summary

This qualitative study explores how patients deal with the side effects from chemotherapy at their home, what factors and ideas influence their symptom self-management and how professional caregivers contribute to the management of their symptoms at home. Data are collected through semi-structured interviews with adult patients treated with chemotherapy and analysed using a Grounded Theory approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2013

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 4, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

November 18, 2014

Status Verified

November 1, 2014

Enrollment Period

1.3 years

First QC Date

May 19, 2013

Last Update Submit

November 17, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • patient's experience

    one interview during the course of treatment, i.e. one timepoint between 2 months after the start of chemotherapy and the end of the patient's treatment

Study Arms (1)

Chemotherapy, Cancer

Adult cancer patients (with any type of cancer) being treated with chemotherapy

Other: No intervention

Interventions

Chemotherapy, Cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients treated with chemotherapy

You may qualify if:

  • Adult (≥18 years) patients with (any type and any stage of) cancer who were undergoing chemotherapy treatment in an ambulatory setting or during short hospital stays
  • Dutch speaking
  • Able to provide informed consent and to participate in an interview

You may not qualify if:

  • Patients who were in the first 2 cycles of treatment
  • Patients for whom an interview was considered physically, mentally and/or emotionally too burdensome.
  • Patients who had reported not to experience any side effect from treatment at all

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Belgium

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Nurse Specialist Oncology

Study Record Dates

First Submitted

May 19, 2013

First Posted

June 4, 2013

Study Start

September 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

November 18, 2014

Record last verified: 2014-11

Locations